🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dont miss Misha Hawkins talk about outpatient #CART operations! ASTCT MD Anderson Cancer Center #ASTCT25

New #IMWG definition of high risk #mmsm and testing challenges and options in broader clinics, presented by Dr. Faith Davies New York University #NashvilleHeme25

Why did we have fludarabine or saline shortage as one of the wealthiest country in the world? Jason Westin, MD FACP FASCO explains the “race to the bottom”. #NashvilleHeme25 clinical & ethical considerations and importance of advocacy

If you now consider the ude of QUADs PFS at 4 years in excess of 80%.. we are at the threshold of curing a significant fraction of standard ridk #mmsm

Our open access article “BCMA-directed CAR T-cell Therapy in patients with multiple myeloma and CNS involvement” is now available online (link below). #mmsm #cart Krina Patel authors.elsevier.com/sd/article/S24…

On the sidelines of CAR T and bispecific meeting in Boston Krina Patel Gurbakhash Kaur Bloodbytes

👉👉 Faculty pic from the recent CAR T and Bispecific meeting in Boston MD Education Noopur Raje Sattva Neelapu Marco Ruella Krina Patel Gurbakhash Kaur Yi Lin Bloodbytes Irene Ghobrial Tycel Phillips Marlise R. Luskin MD, MSCE Matthew Davids, MD, MMSc Sham Mailankody Matt Frank and many others

Dr Michelle Hildebrandt presenting at AYA lymphoma scientific workshop & consortium on her research on #lymsm late effects Lymphoma Research Foundation Andrew M. Evens, DO, MBA, MSc MD Anderson Cancer Center

Effective and safe treatment for this disease! #bispecificrocks BU Amyloidosis Center Teclistamab therapy for refractory type 1 cryoglobulinemia pubmed.ncbi.nlm.nih.gov/40109179/

👉👉👉Farewell reception for our own great friend & wonderful colleague - Dr Hans Lee ! We wish him well as he heads to Sarah Cannon Docs ! Thx for organizing Dr Krina Patel Naveen Pemmaraju, MD Krina Patel Tapan Kadia | Vivek Subbiah, MD Jason Westin, MD FACP FASCO Sanam Loghavi, MD صنم لغوی 🔬🧬 Naval Daver, M.D. #mmsm

Outcomes of older patients (>/= 75) with RRMM treated with teclistamab. No significant difference in CRS, ICANS or ORR #mmsm #bmtsm #Osvolsky Blood Cancer Journal nature.com/articles/s4140…

Join Sagar Lonial, MD, FACP (Sagar Lonial MD), Hans Lee, MD (Hans Lee), and Krina Patel, MD, MSc (Krina Patel), on 5/31 at 6:30 PM CDT during #ASCO25 for a #MultipleMyeloma #MedEd event. Produced with HealthTree Foundation. bit.ly/25MM-T #hematology #oncology #HemOnc

Proteasome inhibition as an anti-cancer strategy was an early idea. The idea was that it will lead to accumulation of proteins and apoptosis. Among the first to develop a proteasome inhibitor was Marion Orlowski, father of the myeloma expert Robert Orlowski Robert Z. Orlowski

Excited to discuss all the updates for multiple myeloma and how to improve outcomes for our patients with my fabulous colleagues Sagar Lonial MD and Hans Lee! #mmsm #ASCO25

Join our experts to explore emerging targeted therapies for high-risk B-cell malignancies. Catch the discussion in booth 10059 on Sunday, June 1, at 12 p.m. #ASCO25 #EndCancer (2/6) Krina Patel Michael Wang, MD Jason Westin, MD FACP FASCO

The NextGen Disruptor Award, given in partnership w/ Healio Community, goes to Nazli Dizman! Dr. Dizman is... 💚 a second-year fellow at MD Anderson Cancer Center 💚 a voice for international medical graduates 💚 contributing to renal cell carcinoma research Congratulations!